Clinical and neurohumoral consequences of diuretic withdrawal in patients with chronic, stabilized heart failure and systolic dysfunction

被引:33
|
作者
Galve, E
Mallol, A
Catalan, R
Palet, J
Méndez, S
Nieto, E
Diaz, A
Soler-Soler, J
机构
[1] Hosp Gen Hosp Hebron, Serv Cardiol, Barcelona 08035, Spain
[2] Hosp Gen Univ Hebron, Serv Bioquim, Barcelona, Spain
关键词
heart failure; diuretics; neurohumoral activation;
D O I
10.1016/j.ejheart.2004.09.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Loop diuretics are beneficial in heart failure in the short term because they eliminate fluid retention, but in the long-term, they could adversely influence prognosis due to activation of neurohumoral mechanisms. Aims: To explore the changes induced by diuretic withdrawal in chronic nonadvanced heart failure. Methods: Diuretics were withdrawn in 26 stabilized heart failure patients with systolic dysfunction (ejection fraction [EF]< 45%). Clinical status was evaluated by physical exam, exercise capacity (corridor test) and New York Heart Association (NYHA) class. Biochemical and neurohumoral determinations were performed at baseline and at 3 months. Results: At 3 months, 17 out of 26 patients (65%) were able to tolerate diuretic interruption without a deterioration in exercise capacity or New York Heart Association functional class. Renal function parameters improved (baseline urea 46.2 +/- 10.8 to 39.2 +/- 10.1 mg/dl at 3 months, p=0.014; creatinine 1.1 +/- 0.23 to 0.98 +/- 0.2 mg/dl, p=0.013). Glucose metabolism also improved (fasting glucose 151 91 to 122 +/- 14 mg/dl, p=0.035). Heart rate and systolic blood pressure did not significantly change, while diastolic blood pressure increased (from 80 +/- 10 to 87 +/- 13 mm Hg, p=0.006). Neurohumoral determinations showed a decrease in plasma renin activity (4.19 +/- 5.96 to 2.88 +/- 4.98 ng/ml, p=0.026), with no changes in aldosterone, arginine-vasopressin, endothelin-1 and norepinephrine. In contrast, atrial natriuretic peptide significantly increased (115 +/- 87 to 168 +/- 155 pg/ml, p=0.004). Conclusion: Diuretic withdrawal in stabilized heart failure with systolic dysfunction is associated with an improvement in renal function parameters, glucose metabolism and some neurohumoral parameters, such as plasma renin activity; however, atrial natriuretic peptide levels increased. (c) 2004 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:892 / 898
页数:7
相关论文
共 50 条
  • [31] Clinical and neurohormonal correlates of sexual dysfunction in patients with chronic heart failure
    Tsiltlakidis, K.
    Varounis, C.
    Parissis, J.
    Lagou, S.
    Birmpa, D.
    Psarogiannakopoulos, P.
    Filippatos, G.
    Anastasiou-Nana, M.
    Kremastinos, D. T.
    EUROPEAN HEART JOURNAL, 2010, 31 : 466 - 466
  • [32] Relation of loop diuretic dose to mortality in advanced heart failure and left ventricular systolic dysfunction
    Redondo, B.
    Hurtado, J. A.
    Pascual Figal, D. A.
    Penafiel, P.
    Garrido, I. P.
    Pastor, F.
    Giner, J. A.
    Valdes, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2007, 6 : 16 - 16
  • [33] The Study for the Patients of Renal Dysfunction on Clinical Outcomes with Chronic Heart Failure
    Li, Jin-Ping
    Zhang, Feng-Ru
    CIRCULATION, 2010, 122 (02) : E231 - E231
  • [34] Diuretic prescribing for patients with heart failure and chronic kidney disease in decompensated heart failure
    Ryan, D. K.
    Mandarano, L.
    Anderson, L.
    Jouhra, F.
    Banerjee, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 281 - 282
  • [35] The treatment of chronic heart failure due to left ventricular systolic dysfunction
    Gardner, RS
    McDonagh, TA
    CLINICAL MEDICINE, 2004, 4 (01) : 18 - 22
  • [36] New and Emerging Drugs and Device Therapies for Chronic Heart Failure in Patients With Systolic Ventricular Dysfunction
    Rouleau, Jean L.
    CANADIAN JOURNAL OF CARDIOLOGY, 2011, 27 (03) : 296 - 301
  • [37] Chronic furosemide use and survival in patients with heart failure secondary to left ventricular systolic dysfunction
    Dini, F. L.
    Ghio, S.
    Rossi, A.
    Temporelli, P. L.
    Capozza, P.
    Maggi, G.
    Genta, F. Tarro
    Santonato, V.
    Di Bello, V.
    Marzilli, M.
    EUROPEAN HEART JOURNAL, 2010, 31 : 132 - 132
  • [38] Renal dysfunction versus preserved renal function in chronic systolic heart failure: which patients?
    Liashenko, A. V.
    Dudnik, A. E.
    Gavrilenko, T. I.
    Ponomareva, G. V.
    Voronkov, L. G.
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 : 281 - 282
  • [39] Global longitudinal strain as a potential prognostic marker in patients with chronic heart failure and systolic dysfunction
    Rangel, Ines
    Goncalves, Alexandra
    de Sousa, Carla
    Almeida, Pedro Bernardo
    Rodrigues, Joao
    Macedo, Filipe
    Cardoso, Jose Silva
    Maciel, Ma Julia
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2014, 33 (7-8) : 403 - 409
  • [40] Sleep apnea prevalence in chronic heart failure patients with severe left ventricle systolic dysfunction
    Hlasensky, Jiri
    Zikmund-Galkova, Lujza
    Ludka, Ondrej
    BIOMEDICAL PAPERS-OLOMOUC, 2017, 161 : S12 - S14